In individuals with severe coronary symptoms, high platelet reactivity (PR) is connected with an increased threat of supplementary thrombotic events. and preprocedural versus non-e). Remarkably, among non-P2Y12 inhibitor users, the PFS was reduced patients with unpredictable CAD weighed against steady CAD (5.6??1.8 vs. 7.4??1.6; The platelet activation check (PACT) reaction blend was prepared beforehand and… Continue reading In individuals with severe coronary symptoms, high platelet reactivity (PR) is